v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2026
Jun. 30, 2025
 Current assets:    
 Cash $ 43,553 $ 4,441
 Prepaid expenses 17,496 15,602
 Deposits and other assets 10,029 9,190
 Total current assets 71,078 29,233
 Property and equipment, net (Note 3) 0 0
 Total assets 71,078 29,233
 Current liabilities:    
 Accounts payable and accrued expenses 2,626,928 2,764,769
 Deferred compensation (Note 4) 1,254,772 1,173,237
 Convertible notes payable (Note 5) 1,807,110 2,310,402
 Convertible bridge note payable (Note 5) 482,206 454,957
 Note payable - related party (Note 5) 466,521 423,053
 Demand note payable 26,323 0
 Total current liabilities 6,663,860 7,126,418
 Total liabilities 6,663,860 7,126,418
 Bion's stockholders' equity (deficit):    
 Common stock, no par value, 250,000,000 shares authorized,  58,116,620 and 57,386,476 shares issued, respectively;  57,412,311 and 56,682,167 shares outstanding, respectively 0 0
 Shares to be issued 1,540,349 0
 Additional paid-in capital 134,497,032 134,677,594
 Subscription receivable - affiliates (Note 7) 0 (504,650)
 Accumulated deficit (142,667,736) (141,307,702)
 Total Bion's stockholders’ equity (deficit) (6,630,355) (7,134,758)
 Noncontrolling interest 37,573 37,573
 Total equity (deficit) (6,592,782) (7,097,185)
 Total liabilities and (deficit) 71,078 29,233
Series A Preferred Stock [Member]    
 Bion's stockholders' equity (deficit):    
Preferred stock, value 0 0
Series C Preferred Stock [Member]    
 Bion's stockholders' equity (deficit):    
Preferred stock, value $ 0 $ 0